Praxis’ Campaign Saves 12 Weeks Off Enrollment Goal For Women’s Health Vaccine Study
Nov 5th 2007Drug InformationPain / Anesthetics
Praxis, a company specializing in centralized patient recruitment for clinical trials, recently provided services to a major pharmaceutical company for a national vaccine research study. The study explored an investigational vaccine for a significant female health issue. Through a combination of site efforts and a targeted, centralized recruitment program, the original enrollment goal of 26 weeks was met in just 14 weeks. [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
